4.8 Article

Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload

Johannes Backs et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Cardiac & Cardiovascular Systems

Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy

Paul Knaapen et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)

Review Hematology

MCAT elements and the TEF-1 family of transcription factors in muscle development and disease

Tadashi Yoshida

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)

Article Pharmacology & Pharmacy

IMPACT OF MULTIPLE GENE MUTATIONS IN DETERMINING THE SEVERITY OF CARDIOMYOPATHY AND HEART FAILURE

Tatiana Tsoutsman et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)

Article Biochemistry & Molecular Biology

GLUT4 enhancer factor (GEF) interacts with MEF2A and HDAC5 to regulate the GLUT4 promoter in adipocytes

David P. Sparling et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Medicine, Research & Experimental

The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice

Yuri Kim et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Article Cardiac & Cardiovascular Systems

Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy on relation to delayed enhancement on cardiovascular magnetic resonance

A. Selcuk Adabag et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)

Article Multidisciplinary Sciences

Requirement of protein kinase D1 for pathological cardiac remodeling

Jens Fielitz et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Rheumatology

Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?

Gillian Murphy et al.

NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)

Review Cardiac & Cardiovascular Systems

Return to the fetal gene program protects the stressed heart: a strong hypothesis

Mitra Rajabi et al.

HEART FAILURE REVIEWS (2007)

Review Developmental Biology

MEF2: a central regulator of diverse developmental programs

Matthew J. Potthoff et al.

DEVELOPMENT (2007)

Article Biochemistry & Molecular Biology

CaMKIIδ isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses

Tong Zhang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Multidisciplinary Sciences

Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo

Kumar Pandya et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Medicine, Research & Experimental

CaM kinase II selectively signals to histone deacetylase 4 during cardiornyocyte hypertrophy

Johannes Backs et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Multidisciplinary Sciences

Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia

CM Wolf et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Cardiac & Cardiovascular Systems

Gene expression in fibroblasts and fibrosis - Involvement in cardiac hypertrophy

I Manabe et al.

CIRCULATION RESEARCH (2002)

Article Biochemistry & Molecular Biology

Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor

FJ Naya et al.

NATURE MEDICINE (2002)

Article Medicine, Research & Experimental

An abnormal Ca2+ response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy

D Fatkin et al.

JOURNAL OF CLINICAL INVESTIGATION (2000)